Evidence map›Paper›PMID 29765506›Full record

ArticleOxidative medicine and cellular longevity2018

6'-

Zhongmei Wen, Weichen Hou, Wei Wu, Yang Zhao, Xuechao Dong, Xiaoxue Bai, Liping Peng, Lei Song

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 121 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in microbiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metabolomics: A useful tool for ischemic stroke research.Journal of pharmaceutical analysis · 2023
    Review
  13. Pharmaceutical Therapies for Necroptosis in Myocardial Ischemia-Reperfusion Injury.Journal of cardiovascular development and disease · 2023
    Review
  14. Article
  15. Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhongmei WenDepartment of Respiratory Medicine, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.
Weichen HouDepartment of Neurology, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.
Wei WuDepartment of Neurosurgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.
Yang ZhaoDepartment of Neurology, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.
Xuechao DongDepartment of Neurosurgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.
Xiaoxue BaiCadre's Ward, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.ORCID 0000-0002-6471-1819
Liping PengDepartment of Respiratory Medicine, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.ORCID 0000-0001-7369-4048
Lei SongDepartment of Respiratory Medicine, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, China.ORCID 0000-0002-4115-065X
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

6'-

Indexed as

AnimalsBrain IschemiaBridged Bicyclo Compounds, HeterocyclicCell Line, TumorGlucosidesMaleMonoterpenesNeuroprotective AgentsOxidative StressPC12 CellsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, WistarReperfusion InjuryBridged Bicyclo Compounds, HeterocyclicgalloylpaeoniflorinGlucosidesMonoterpenesNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID29765506
PMCPMC5889897
OpenAlexW2790043087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.